These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9704451)

  • 41. Use of current generation perfluorocarbon emulsions in cardiac surgery.
    Holman WL; McGiffin DC; Vicente WV; Spruell RD; Pacifico AD
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):979-90. PubMed ID: 7849969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dynamics of arterial pressure and gas exchange in dogs with acute blood loss replaced by an emulsion of carbon tetrafluoride].
    Akhsianov UU; Afonin NI; Troitskiĭ VB
    Gematol Transfuziol; 1983 Apr; 28(4):41-4. PubMed ID: 6852512
    [No Abstract]   [Full Text] [Related]  

  • 43. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part I: oxygen uptake in tubular vessels.
    Patel S; Mehra A
    ASAIO J; 1998; 44(3):144-56. PubMed ID: 9617943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fluorocarbon emulsions--artificial blood?].
    Frick G; Frick U
    Zentralbl Chir; 1982; 107(18):1137-41. PubMed ID: 7180230
    [No Abstract]   [Full Text] [Related]  

  • 45. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H; Knoblich A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substitutes for blood.
    Lowe KC
    Expert Opin Pharmacother; 2001 Jul; 2(7):1057-9. PubMed ID: 11583055
    [No Abstract]   [Full Text] [Related]  

  • 47. Perfluorocarbon blood substitutes.
    Biro GP; Blais P
    Crit Rev Oncol Hematol; 1987; 6(4):311-74. PubMed ID: 3549022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The structure-property correlation: estimates of the half-clearance time of perfluororganic compounds.
    Golovanov IB; Ivanitskii GR; Tsygankova IG; Khabarova MI
    Dokl Biochem; 2000; 371(1-6):63-8. PubMed ID: 10853453
    [No Abstract]   [Full Text] [Related]  

  • 49. Amphiphilic sugar phosphates with single or double perfluoroalkylated hydrophobic chains for use in oxygen and drug delivery systems.
    Guillod F; Greiner J; Milius A; Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1273-9. PubMed ID: 7849933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract]   [Full Text] [Related]  

  • 51. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes.
    Tao Z; Ghoroghchian PP
    Trends Biotechnol; 2014 Sep; 32(9):466-73. PubMed ID: 24929580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Second-generation perfluorocarbon emulsion blood substitutes.
    Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):25-38. PubMed ID: 10676575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology.
    Lowe KC
    Vox Sang; 1991; 60(3):129-40. PubMed ID: 1862635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbohydrate- and related polyol-derived fluorosurfactants: an update.
    Riess JG; Greiner J
    Carbohydr Res; 2000 Jul; 327(1-2):147-68. PubMed ID: 10968680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Red cell substitutes: an update.
    Gould SA; Sehgal LR; Rosen AL; Sehgal HL; Moss GS
    Ann Emerg Med; 1985 Aug; 14(8):798-803. PubMed ID: 4025972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Oxygen supply of the body during the administration organofluorine emulsions (a pathophysiological analysis)].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1988; (3):81-6. PubMed ID: 3050820
    [No Abstract]   [Full Text] [Related]  

  • 58. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(1):95-113. PubMed ID: 1617088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Various physico-chemical and biological properties of perfluorodecalin emulsions].
    Chaplygina ZA; Kuznetsova IN; Gokhman NSh; Domracheva VS; Maksimov BN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):8-12. PubMed ID: 7178053
    [No Abstract]   [Full Text] [Related]  

  • 60. Perfluorocarbon-based red blood cell substitutes.
    Biro GP
    Transfus Med Rev; 1993 Apr; 7(2):84-95. PubMed ID: 8481603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.